2021
DOI: 10.1111/neup.12744
|View full text |Cite
|
Sign up to set email alerts
|

Unexpected postmortem diagnoses in cases of clinically diagnosed amyotrophic lateral sclerosis

Abstract: Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that is clinically and pathologically characterized by impairment of the upper and lower motor neurons. The clinical diagnosis of ALS is not always straightforward because of the lack of specific biomarkers and clinical heterogeneity. This review presents the clinical and pathological findings of four autopsied cases that had been diagnosed with ALS before death. These cases had demonstrated definite and progressive motor neuron signs and symptoms, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 65 publications
0
6
0
Order By: Relevance
“…4 A subset of ALS patients, defined as ALS-Plus, 5 exhibits other nonmotor signs, extrapyramidal or autonomic, that may be clinical or subclinical, the latter usually revealed on pathological postmortem grounds. 6 Based on the above, ALS can be considered a multisystem degenerative disease. [7][8][9][10] Regarding autonomous nervous system (ANS) involvement, several researchers have investigated heart rate variability (HRV) as a measure of dysautonomia in ALS patients.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…4 A subset of ALS patients, defined as ALS-Plus, 5 exhibits other nonmotor signs, extrapyramidal or autonomic, that may be clinical or subclinical, the latter usually revealed on pathological postmortem grounds. 6 Based on the above, ALS can be considered a multisystem degenerative disease. [7][8][9][10] Regarding autonomous nervous system (ANS) involvement, several researchers have investigated heart rate variability (HRV) as a measure of dysautonomia in ALS patients.…”
Section: Introductionmentioning
confidence: 99%
“…It is estimated that half of patents with ALS experience cognitive or behavioral impairment, 3 a percentage of whom develop frontotemporal dementia 4 . A subset of ALS patients, defined as ALS‐Plus, 5 exhibits other nonmotor signs, extrapyramidal or autonomic, that may be clinical or subclinical, the latter usually revealed on pathological postmortem grounds 6 . Based on the above, ALS can be considered a multisystem degenerative disease 7–10 …”
Section: Introductionmentioning
confidence: 99%
“…The authors disclose no conflict of interest. Shinobu Kawakatsu, 1 Toshiki Uchihara, 2,3,4 Masaki Takao 5 and Noriyuki Shibata…”
Section: Disclosurementioning
confidence: 99%
“…Traditionally, in Japan, dedicated psychiatrists and neurologists have made great efforts to evaluate the heterogeneity of these neuropsychiatric symptoms neuropathologically as well as neuropsychologically. Herein, neurodegenerative diseases with primary progressive aphasia or late‐onset psychosis that have recently attracted attention in clinical settings are presented as sequels to the Neuropathological Case Cluster ( NCC ), inaugurated in Neuropathology 1–5 . NCC will increase the significance of case reports by contrasting multiple cases and encourage many researchers to report case series.…”
mentioning
confidence: 99%
See 1 more Smart Citation